Skip to content

Clinical trials

Hepatitis, Alcoholic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Alcoholic Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20102
20135
20145
20163
20171
20181
20193
20204
20213
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting6
Terminated6
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Indiana University4
Conatus Pharmaceuticals Inc.2
Durect2
HepQuant, LLC2
Johns Hopkins University2
The Cleveland Clinic2
Virginia Commonwealth University2
Aldeyra Therapeutics, Inc.1
Bausch Health Americas, Inc.1
Craig James McClain1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Alcoholic36
Fibrosis4
Hepatitis4
Alcoholism2
Liver Cirrhosis, Alcoholic2
Liver Diseases2
Liver Diseases, Alcoholic2
Liver Failure2
Liver Failure, Acute2
Renal Insufficiency2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.